Deutsche Bank AG Acquires New Shares in LifeStance Health Group, Inc. $LFST

Deutsche Bank AG acquired a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the second quarter, HoldingsChannel.com reports. The firm acquired 217,798 shares of the company’s stock, valued at approximately $2,333,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Larson Financial Group LLC boosted its holdings in shares of LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after acquiring an additional 3,791 shares during the period. KBC Group NV acquired a new stake in shares of LifeStance Health Group in the 1st quarter worth about $29,000. EverSource Wealth Advisors LLC increased its holdings in shares of LifeStance Health Group by 359.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after acquiring an additional 5,404 shares during the period. Bayesian Capital Management LP bought a new stake in LifeStance Health Group in the 2nd quarter valued at about $52,000. Finally, PNC Financial Services Group Inc. lifted its position in LifeStance Health Group by 615.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after purchasing an additional 7,987 shares during the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have commented on LFST shares. Weiss Ratings upgraded shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. lifted their price target on LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. KeyCorp boosted their price objective on LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Wall Street Zen raised LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 15th. Finally, BTIG Research raised their target price on LifeStance Health Group from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, LifeStance Health Group has a consensus rating of “Moderate Buy” and an average price target of $12.38.

Insider Buying and Selling at LifeStance Health Group

In other news, CTO Vukasin Paunovich sold 44,394 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $481,674.90. Following the transaction, the chief technology officer owned 247,446 shares of the company’s stock, valued at $2,684,789.10. The trade was a 15.21% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Robert Bessler sold 894,337 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $10.13, for a total transaction of $9,059,633.81. Following the completion of the sale, the director owned 539,763 shares in the company, valued at $5,467,799.19. The trade was a 62.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 14,629,850 shares of company stock valued at $154,952,012 in the last ninety days. 3.50% of the stock is owned by insiders.

LifeStance Health Group Stock Up 1.2%

Shares of LFST stock opened at $12.30 on Friday. LifeStance Health Group, Inc. has a 1 year low of $4.77 and a 1 year high of $12.97. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The business’s fifty day moving average is $11.13 and its 200-day moving average is $8.57. The stock has a market cap of $4.77 billion, a PE ratio of 94.62 and a beta of 1.14.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business had revenue of $435.35 million during the quarter, compared to analyst estimates of $414.58 million. During the same quarter in the prior year, the firm posted ($0.01) earnings per share. The company’s revenue was up 26.1% on a year-over-year basis. Equities analysts expect that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.